Sort by
Refine Your Search
-
Listed
-
Field
-
Stanford University required minimum for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY25 minimum is $76,383. Evolution of asymmetric cell division in spiralian
-
: Experience with molecular virology of HIV or EBV including assay development and reverse genetics OR Experience with cell/molecular biology and protein biochemistry/biophysics, including recombinant protein
-
for (1) engineering BPAN genetic variants into cell lines; (2) developing cellular assays including of autophagy function and cellular survival; (3) working with the Stanford high throughput drug screening
-
and atomic-level assembly of cell walls, extracellular structures, and are constructing blueprints of how bacteria use these building blocks to engineer organized and dynamic architectures. We
-
the precise gene activity and cell-cell interaction between the developing embryo and maternal endometrium. This work addresses a critical factor in human reproduction, as implantation failure remains a major
-
cell fate decisions, particularly during early neural development or during the epithelial-to-mesenchymal transition (EMT) in cancer. Our recent work reveals that coding sequences (CDS) and their cognate
-
tumor spatial biology via single cell spatial analysis of the tumor microenvironment. Projects aim to reveal molecular mechanisms of drug resistance based on intercellular and intracellular regulation
-
imaging; cellular and molecular biology studies and assays including for example cell culture and transfections, qRT-PCR, RNA and DNA isolation and preparation, ELISAs, tissue histology and microscopy, and
-
-genomically templated CD8+ T cell epitopes derived from the proteasome catalyzed splicing of peptides (PCPS). Our work suggests that PCPS peptides are dependent on protein structure and not just the mutated
-
immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell surface cancer proteins (e.g. PSMA, CA9) and